Clinical Trial: A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Facioscapulohumeral Muscular Dystrophy (FSHD)
Study Type: INTERVENTIONAL
Official Title: A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Pharmacodynamics, Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7204239 in Participants With Fac
Brief Summary:
The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and efficacy of RO7204239, a humanized monoclonal antibody that binds to human latent myostatin, in ambulant adult participants with facioscapulohumeral muscular dystrophy (FSHD).
Read more